Enhancing Participation of Chronic Stroke Patients by Constraint Induced Movement Therapy (HOMECIMT) (HOMECIMT)
Primary Purpose
Stroke
Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
mod. Constraint-Induced Movement Therapy
Therapy as usual
Sponsored by

About this trial
This is an interventional treatment trial for Stroke focused on measuring stroke, Constraint Induced Movement Therapy, participation, Physical Therapy, Occupational Therapy
Eligibility Criteria
Inclusion Criteria:
- age ≥ 18 years
- Stroke onset > 6 months prior to study enrollment
- upper extremity hemiparesis with impairment of hand and/or arm
- minimal function of the hand (at least 10º active wrist extension, at least 10º active of thumb abduction/extension, and at least 10º of extension two additional fingers)
- non-professional coach (e.g. family member)
- prescription of physical or occupational therapy
Exclusion Criteria:
- lack of knowledge of German
- serious impairment of verbal communication ability (e.g. severe aphasia)
- inability to consent (e.g. dementia)
- severe neuro-cognitive deficits (MMSE <23)
- terminal illness, life-threatening co-morbidity
- simultaneous participation in another treatment study targeting stroke recovery
- subjects may not have already received constraint induced movement therapy
Sites / Locations
- Department of Primary Medical Care, University Medical Center Hamburg-Eppendorf
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Other
Arm Label
mod. Constraint-Induced Movement Therapy
Therapy as usual
Arm Description
CIMT at home is applied in the patients' home over the course of four weeks including (i.e. 20 consecutive days) 2 hours of daily training together with an instructed non-professional coach (e.g. family member) applying shaping techniques.
Patients in this arm will receive usual care dose-matched to the intervention group (250-300 minutes).
Outcomes
Primary Outcome Measures
Motor Activity Log - Quality Of Movement (MAL-QOM) and Wolf Motor Function Test - Performance Time (WMFT-PT)
"Participation" defined as equal involvement in all aspects of society and daily living for people with disabilities is a composite outcome of the following two measures: The MAL-QOM is a self-administered measure of how well 30 daily activities are performed to assess the change in the quality of arm and hand use and the WMFT-PT, measured as the average time (in seconds) to complete 15 tasks, to evaluate the change in arm and hand function.
Secondary Outcome Measures
Motor Activity Log - Quality Of Movement (MAL-QOM) and MAL- Amount Of Use (MAL-AOU)
to assess the change in the quality and amount of arm and hand use
Wolf Motor Function Test - Performance Time (WMFT-PT) and WMFT Functional Ability (WMFT-FA)
to assess the change in time and quality of movement
Nine-Hole Peg-Test
to assess finger dexterity
Stroke-Impact-Scale (SIS)
to assess the impact on health and quality of life. A self-administered 59-item questionnaire, which assesses 8 domains of stroke (Strength, Hand Function, Activities of Daily Living / Instrumental Activities of Daily Living, Mobility, Communication, Emotion, Memory and Thinking, and Participation)
Barthel Index(BI)
to assess functional disability i.e. to which somebody can function independently and has mobility in their activities of daily living (ADL)
Instrumental Activities of Daily Living Scale (IADL)
to asses self-maintaining and instrumental activities of daily living
Full Information
NCT ID
NCT01343602
First Posted
April 26, 2011
Last Updated
December 14, 2014
Sponsor
Universitätsklinikum Hamburg-Eppendorf
Collaborators
German Federal Ministry of Education and Research
1. Study Identification
Unique Protocol Identification Number
NCT01343602
Brief Title
Enhancing Participation of Chronic Stroke Patients by Constraint Induced Movement Therapy (HOMECIMT)
Acronym
HOMECIMT
Official Title
Enhancing Participation of Chronic Stroke Patients in Primary Care by Modified Constraint Induced Movement Therapy (HOMECIMT)
Study Type
Interventional
2. Study Status
Record Verification Date
December 2014
Overall Recruitment Status
Completed
Study Start Date
October 2011 (undefined)
Primary Completion Date
June 2013 (Actual)
Study Completion Date
June 2013 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Universitätsklinikum Hamburg-Eppendorf
Collaborators
German Federal Ministry of Education and Research
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of this study is to evaluate the efficacy of a modified approach of constraint induced movement therapy ("CIMT at home") for chronic stroke patients, compared to conventional physiotherapy and occupational therapy ("therapy as usual) with regard to the ability to participate in everyday activities.
Detailed Description
The study is a parallel cluster randomized controlled trial with therapy practices as clusters. After written consent from the patients, the therapists are randomly assigned to treat either the intervention or the control group. Blinded external assessors evaluate the patients using standardized outcome measures before and after the intervention, and six months later. The two coprimary endpoint assessments of arm and hand function as prerequisites for participation (defined as equal involvement in activities of daily living) are quality of arm and hand use and arm and hand function. Assessments are made four weeks post-treatment and relativized to baseline performance. Changes in primary outcomes are analyzed with mixed models, which consider the hierarchical structure of the data, adjusted to the baseline measurements and sex. The primary analysis compares the two randomized groups, with respect to the adjusted averages for each of the two coprimary endpoints. To keep an overall significance level of 5%, the two endpoints are tested at the significance level of 5% each in hierarchical order.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke
Keywords
stroke, Constraint Induced Movement Therapy, participation, Physical Therapy, Occupational Therapy
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
156 (Actual)
8. Arms, Groups, and Interventions
Arm Title
mod. Constraint-Induced Movement Therapy
Arm Type
Experimental
Arm Description
CIMT at home is applied in the patients' home over the course of four weeks including (i.e. 20 consecutive days) 2 hours of daily training together with an instructed non-professional coach (e.g. family member) applying shaping techniques.
Arm Title
Therapy as usual
Arm Type
Other
Arm Description
Patients in this arm will receive usual care dose-matched to the intervention group (250-300 minutes).
Intervention Type
Behavioral
Intervention Name(s)
mod. Constraint-Induced Movement Therapy
Intervention Description
Therapists of the intervention group are trained in "CIMT at home". During an initial home visit the therapist determines together with the patient an individually tailored home training program focussing on everyday practice and instructs the non-professional coach. For four weeks the patients will perform 2 hours of daily training at home together with an instructed non-professional coach (e.g. family member) applying shaping techniques (i.e. 20 consecutive days). Patients are supposed to wear a resting hand splint for the entire treatment period for 4 to 6 hours daily. During the four weeks the therapist will provide 5 weekly visits at the patients' home to instruct and supervise the training.
Intervention Type
Other
Intervention Name(s)
Therapy as usual
Intervention Description
Therapy as usual consists of the therapy, which is usually provided by the occupational or physical therapist. Therapy will be applied at the patients home or at the therapists' practice.
Primary Outcome Measure Information:
Title
Motor Activity Log - Quality Of Movement (MAL-QOM) and Wolf Motor Function Test - Performance Time (WMFT-PT)
Description
"Participation" defined as equal involvement in all aspects of society and daily living for people with disabilities is a composite outcome of the following two measures: The MAL-QOM is a self-administered measure of how well 30 daily activities are performed to assess the change in the quality of arm and hand use and the WMFT-PT, measured as the average time (in seconds) to complete 15 tasks, to evaluate the change in arm and hand function.
Time Frame
4 weeks (post-treatment) relative to baseline performance
Secondary Outcome Measure Information:
Title
Motor Activity Log - Quality Of Movement (MAL-QOM) and MAL- Amount Of Use (MAL-AOU)
Description
to assess the change in the quality and amount of arm and hand use
Time Frame
3 and 6 months relative to baseline performance
Title
Wolf Motor Function Test - Performance Time (WMFT-PT) and WMFT Functional Ability (WMFT-FA)
Description
to assess the change in time and quality of movement
Time Frame
6 months relative to baseline performance
Title
Nine-Hole Peg-Test
Description
to assess finger dexterity
Time Frame
4 weeks (post-treatment) and 6 months relative to baseline performance
Title
Stroke-Impact-Scale (SIS)
Description
to assess the impact on health and quality of life. A self-administered 59-item questionnaire, which assesses 8 domains of stroke (Strength, Hand Function, Activities of Daily Living / Instrumental Activities of Daily Living, Mobility, Communication, Emotion, Memory and Thinking, and Participation)
Time Frame
4 weeks (post-treatment) and 6 months relative to baseline performance
Title
Barthel Index(BI)
Description
to assess functional disability i.e. to which somebody can function independently and has mobility in their activities of daily living (ADL)
Time Frame
4 weeks (post-treatment) and 6 months relative to baseline performance
Title
Instrumental Activities of Daily Living Scale (IADL)
Description
to asses self-maintaining and instrumental activities of daily living
Time Frame
4 weeks (post-treatment) and 6 months relative to baseline performance
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
age ≥ 18 years
Stroke onset > 6 months prior to study enrollment
upper extremity hemiparesis with impairment of hand and/or arm
minimal function of the hand (at least 10º active wrist extension, at least 10º active of thumb abduction/extension, and at least 10º of extension two additional fingers)
non-professional coach (e.g. family member)
prescription of physical or occupational therapy
Exclusion Criteria:
lack of knowledge of German
serious impairment of verbal communication ability (e.g. severe aphasia)
inability to consent (e.g. dementia)
severe neuro-cognitive deficits (MMSE <23)
terminal illness, life-threatening co-morbidity
simultaneous participation in another treatment study targeting stroke recovery
subjects may not have already received constraint induced movement therapy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anne Barzel, MD
Organizational Affiliation
Department of Primary Medical Care, University Medical Center Hamburg-Eppendorf
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Primary Medical Care, University Medical Center Hamburg-Eppendorf
City
Hamburg
ZIP/Postal Code
20246
Country
Germany
12. IPD Sharing Statement
Citations:
PubMed Identifier
26231624
Citation
Barzel A, Ketels G, Stark A, Tetzlaff B, Daubmann A, Wegscheider K, van den Bussche H, Scherer M. Home-based constraint-induced movement therapy for patients with upper limb dysfunction after stroke (HOMECIMT): a cluster-randomised, controlled trial. Lancet Neurol. 2015 Sep;14(9):893-902. doi: 10.1016/S1474-4422(15)00147-7. Epub 2015 Jul 28.
Results Reference
derived
PubMed Identifier
24124993
Citation
Barzel A, Ketels G, Tetzlaff B, Kruger H, Haevernick K, Daubmann A, Wegscheider K, Scherer M. Enhancing activities of daily living of chronic stroke patients in primary health care by modified constraint-induced movement therapy (HOMECIMT): study protocol for a cluster randomized controlled trial. Trials. 2013 Oct 14;14:334. doi: 10.1186/1745-6215-14-334.
Results Reference
derived
Learn more about this trial
Enhancing Participation of Chronic Stroke Patients by Constraint Induced Movement Therapy (HOMECIMT)
We'll reach out to this number within 24 hrs